help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-2095
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VanHouten, J. N.
Right arrow Articles by Udelsman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VanHouten, J. N.
Right arrow Articles by Udelsman, R.
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 2 580-583
Copyright © 2006 by The Endocrine Society

Hypercalcemia of Malignancy due to Ectopic Transactivation of the Parathyroid Hormone Gene

Joshua N. VanHouten, Namyi Yu, David Rimm, Jorge Dotto, Andrew Arnold, John J. Wysolmerski and Robert Udelsman

Department of Internal Medicine (J.N.V., N.Y., J.J.W.), Section of Endocrinology and Metabolism, and Departments of Pathology (D.R., J.D.) and Surgery (R.U.), Yale University School of Medicine, New Haven, Connecticut 06520; and Center for Molecular Medicine and Division of Endocrinology and Metabolism (A.A.), University of Connecticut School of Medicine, Farmington, Connecticut 06303-3101

Address all correspondence and requests for reprints to: John J. Wysolmerski, M.D., Section of Endocrinology and Metabolism, Department of Medicine, Yale University School of Medicine, TAC S131, 333 Cedar Street, New Haven, Connecticut 06520-8020.

Context: The physiology of PTH is well described, but regulation of PTH gene expression remains enigmatic. This is, at least in part, because of a lack of suitable cell culture systems.

Objective, Design, Setting, Patients, Interventions, and Main Outcome Measures: We report a case of severe hyperparathyroidism resulting from the ectopic production of PTH by a pancreatic malignancy. Cells from the primary tumor (PEPP1 cells) were established in culture to examine the etiology of ectopic PTH gene expression in this patient.

Results and Conclusions: We failed to find amplification or rearrangement of the PTH gene but documented hypomethylation of the PTH promoter in tumor tissue. We found that PEPP1 cells support expression of a reporter gene containing regulatory sequences from the human PTH gene promoter. Therefore, this is the first report documenting ectopic PTH production by a tumor as the result of transactivation of the PTH gene. PEPP1 cells may be useful for future studies aimed at elucidating the details of PTH gene regulation.




This article has been cited by other articles:


Home page
Cancer Res.Home page
N. I. Fleming, M. K. Trivett, J. George, J. L. Slavin, W. K. Murray, J. M. Moseley, R. L. Anderson, and D. M. Thomas
Parathyroid Hormone-Related Protein Protects against Mammary Tumor Emergence and Is Associated with Monocyte Infiltration in Ductal Carcinoma In situ
Cancer Res., September 15, 2009; 69(18): 7473 - 7479.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Suva
PTH Expression, Not Always where You Think ...
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 396 - 397.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society